Bioavailability of lycopene in the rat: The role of intestinal lymphatic transport

Journal of Pharmacy and Pharmacology

Volumn 62, Issue 3, 2010, Pages 323-331

  Faisal, Waleed ^a   O'Driscoll, Caitriona M ^a   Griffin, Brendan T ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Gastrointestinal absorption; Intestinal lymphatics; Lipid based formulations; Lycopene bioavailability

Indexed keywords

BILE SALT; LYCOPENE; LYCOVIT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG SOLUBILITY; DRUG TISSUE LEVEL; DRUG TRANSPORT; INTESTINE FLUID; INTESTINE LYMPH; LYMPH VESSEL; MALE; MAXIMUM PLASMA CONCENTRATION; MESENTERY LYMPH NODE; MICELLE; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; RAT; SIMULATION; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; BIOLOGICAL TRANSPORT; CAROTENOIDS; CATHETERIZATION; DIETARY FATS; EMULSIONS; FATTY ACIDS; INTESTINAL ABSORPTION; INTESTINES; KINETICS; LYMPH; LYMPHATIC SYSTEM; LYMPHATIC VESSELS; MALE; RATS; RATS, WISTAR; SOLUBILITY; TRIGLYCERIDES;

EID: 77950281866     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.62.03.0006     Document Type: Article

References (42)

1. Giovannucci, E. A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer. Exp Biol Med (Maywood) 2002 227 : 852 859.
2. Campbell, JK, et al. Tomato phytochemicals and prostate cancer risk. J Nutr 2004 134 : 3486S 3492S.
3. Etminan, M, et al. The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidem Biomarkers Prevention 2004 13 : 340 345.
4. Giovannucci, E. Tomato products, lycopene, and prostate cancer: a review of the epidemiological literature. J Nutr 2005 135 : 2030S 2031S.
5. Lindshield, BL, et al. Lycopenoids: are lycopene metabolites bioactive?. Arch Biochem Biophys 2007 458 : 136 140.
6. Boileau, TOM, et al. Lycopene isomers and carotenoid profiles in African American (Aa) and Caucasian (C) men. Faseb J 1998 12 : A856 A856.
7. Giovannucci, E. Does prostate-specific antigen screening influence the results of studies of tomatoes, lycopene, and prostate cancer risk?. J Natl Cancer Inst 2007 99 : 1060 1062.
8. Porrini, M. Riso, P. What are typical lycopene intakes?. J Nutr 2005 135 : 2042S 2045S.
9. Stahl, W. Sies, H. Lycopene: a biologically important carotenoid for humans?. Arch Biochem Biophys 1996 336 : 1 9.
10. Gartner, C, et al. Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am J Clin Nutr 1997 66 : 116 122.
11. Castenmiller, JJ, et al. The food matrix of spinach is a limiting factor in determining the bioavailability of beta-carotene and to a lesser extent of lutein in humans. J Nutr 1999 129 : 349 355.
12. Cohn, W, et al. Comparative multiple dose plasma kinetics of lycopene administered in tomato juice, tomato soup or lycopene tablets. Eur J Nutr 2004 43 : 304 312.
13. Vertzoni, M, et al. Plasma profiles of lycopene after single oral and intravenous administration in dogs. J Pharm Pharmacol 2006 58 : 1211 1217.
14. O'Driscoll, CM. Lipid based formulations for intestinal lymphatic delivery. Eur J Pharm Sci 2002 15 : 405 415.
15. Amidon, GL, et al. A theoretical basis for a biopharmaceutic drug classification-the correlation of in-vitro drug product dissolution and in-vivo bioavailability. Pharm Res 1995 12 : 413 420.
16. Cao, X, et al. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model?. Pharm Res 2006 23 : 1675 1686.
17. Budavari S et al. eds. The Merck Index. An Encyclopedia of Chemicals, Drugs and Biologicals, 12th edn. NJ : Merck research laboratories, Division of Merck & Co., Inc., 1996.
18. Sicilia, T, et al. Novel lycopene metabolites are detectable in plasma of preruminant calves after lycopene supplementation. J Nutr 2005 135 : 2616 2621.
19. Marques M. US Pharmacopeia. Rockville, MD : US Pharmacopeia, 2004.
20. Vertzoni, M, et al. Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects. J Pharm Pharmacol 2004 56 : 453 462.
21. Griffin, BT. O'Driscoll, CM. A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model. J Pharm Pharmacol 2006 58 : 917 925.
22. Vertzoni, MV, et al. Optimized determination of lycopene in canine plasma using reversed-phase high-performance liquid chromatography. J Chromatogr B 2005 819 : 149 154.
23. Parker, RS, et al. Bioavailability of carotenoids in human subjects. Proc Nutr Soc 1999 58 : 155 162.
24. Nishimukai, M. Hara, H. Enteral administration of soybean phosphatidylcholine enhances the lymphatic absorption of lycopene, but reduces that of alpha-tocopherol in rats. J Nutr 2004 134 : 1862 1866.
25. Britton, G. Structure and properties of carotenoids in relation to function. FASEB J 1995 9 : 1551 1558.
26. Kostewicz, ES, et al. Forecasting the oral absorption behavior of poorly soluble weak bases using solubility and dissolution studies in biorelevant media. Pharm Res 2002 19 : 345 349.
27. Diwadkar-Navsariwala, V, et al. A physiological pharmacokinetic model describing the disposition of lycopene in healthy men. J Lipid Res 2003 44 : 1927 1939.
28. Humberstone, AJ. Charman, WN. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev 1997 25 : 103 128.
29. MacGregor, KJ, et al. Influence of lipolysis on drug absorption from the gastro-intestinal tract. Adv Drug Deliv Rev 1997 25 : 33 46.
30. Kossena, GA, et al. Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs. J Pharm Sci 2003 92 : 634 648.
31. Kossena, GA, et al. Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach. J Pharm Sci 2004 93 : 332 348.
32. Korytko, PJ, et al. Pharmacokinetics and tissue distribution of orally administered lycopene in male dogs. J Nutr 2003 133 : 2788 2792.
33. Gustin, DM, et al. Single-dose pharmacokinetic study of lycopene delivered in a well-defined food-based lycopene delivery system (tomato paste-oil mixture) in healthy adult male subjects. Cancer Epidemiol Biomarkers Prev 2004 13 : 850 860.
34. Stahl, W. Sies, H. Uptake of lycopene and its geometrical-isomers is greater from heat-processed than from unprocessed tomato juice in humans. J Nutr 1992 122 : 2161 2166.
35. Tang, GW, et al. Bioavailability of synthetic and biosynthetic deuterated lycopene in humans. J Nutr Biochem 2005 16 : 229 235.
36. Hauss, DJ, et al. Targeted lymphatic transport and modified systemic distribution of CI-976, a lipophilic lipid-regulator drug, via a formulation approach. Int J Pharm 1994 108 : 85 93.
37. Caliph, SM, et al. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J Pharm Sci 2000 89 : 1073 1084.
38. Khoo, SM, et al. Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs. Pharm Res 2003 20 : 1460 1465.
39. Griffin, BT. O'Driscoll, CM. An examination of the effect of intestinal first pass extraction on intestinal lymphatic transport of saquinavir in the rat. Pharm Res 2008 25 : 1125 1133.
40. Charman, WN. Stella, VJ. Effect of lipid class and lipid vehicle volume on the intestinal lymphatic transport of DDT. Int J Pharm 1986 33 : 165 172.
41. Porter, CJ, et al. Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion. J Pharm Sci 1996 85 : 351 356.
42. Trevaskis, NL, et al. The lymph lipid precursor pool is a key determinant of intestinal lymphatic drug transport. J Pharmacol Exp Ther 2006 316 : 881 891.